Suppr超能文献

非甾体类抗炎眼药水对原发性开角型青光眼或高眼压症患者使用拉坦前列素降低眼压的影响。

Effect of non-steroidal anti-inflammatory ophthalmic solution on intraocular pressure reduction by latanoprost in patients with primary open angle glaucoma or ocular hypertension.

作者信息

Chiba T, Kashiwagi K, Chiba N, Tsukahara S

机构信息

Department of Ophthalmology, University of Yamanashi Faculty of Medicine, 1110 Shimokato, Tamaho, Yamanashi 409-3898, Japan.

出版信息

Br J Ophthalmol. 2006 Mar;90(3):314-7. doi: 10.1136/bjo.2005.080895.

DOI:10.1136/bjo.2005.080895
PMID:16488953
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1856952/
Abstract

AIM

To investigate the effects of a non-steroidal anti-inflammatory drug (NSAID) ophthalmic solution on latanoprost induced intraocular pressure (IOP) reduction in glaucoma patients.

METHODS

Examination was conducted on 16 eyes of 16 glaucoma patients who had been given only latanoprost for at least 6 weeks. The NSAID ophthalmic solution, sodium 2-amino-3-(4-bromobenzoyl) phenylacetate sesquihydrate, was additionally given for 12 weeks into one eye (NSAID group), while sodium hyaluronic acid ophthalmic solution was administered into the other eye (control group) in a double masked fashion. The IOP measurement was performed before the start of additional administration of ophthalmic solutions, 2, 4, 6, 8, 10, and 12 weeks after the start of additional administration, and 2, 4, and 6 weeks after discontinuing additional administration.

RESULTS

No significant difference was observed in the IOPs before additional administration of ophthalmic solution between the NSAID group and the control group. Following the additional administration of ophthalmic solution, IOP in the NSAID group was consistently higher than that in the control group, and a maximum difference in IOP between the two groups was 1.08 (SD 1.75) mm Hg (p = 0.03). This trend was observed even after additional administration was discontinued.

CONCLUSION

NSAID ophthalmic solution may partly affect IOP reduction by latanoprost.

摘要

目的

研究一种非甾体抗炎药（NSAID）眼药水对青光眼患者使用拉坦前列素降低眼压（IOP）效果的影响。

方法

对16例青光眼患者的16只眼睛进行检查，这些患者仅使用拉坦前列素至少6周。以双盲方式，一只眼睛额外给予NSAID眼药水2 -氨基- 3 -（4 -溴苯甲酰基）苯乙酸倍半水合物钠12周（NSAID组），另一只眼睛给予透明质酸钠眼药水（对照组）。在额外给予眼药水开始前、开始后2、4、6、8、10和12周以及停止额外给药后2、4和6周进行眼压测量。

结果

NSAID组和对照组在额外给予眼药水前的眼压无显著差异。额外给予眼药水后，NSAID组的眼压始终高于对照组，两组眼压的最大差异为1.08（标准差1.75）mmHg（p = 0.03）。即使在停止额外给药后，这种趋势仍然存在。

结论

NSAID眼药水可能会部分影响拉坦前列素降低眼压的效果。

相似文献

1
Effect of non-steroidal anti-inflammatory ophthalmic solution on intraocular pressure reduction by latanoprost in patients with primary open angle glaucoma or ocular hypertension.非甾体类抗炎眼药水对原发性开角型青光眼或高眼压症患者使用拉坦前列素降低眼压的影响。
Br J Ophthalmol. 2006 Mar;90(3):314-7. doi: 10.1136/bjo.2005.080895.
2
A 6-week, double-masked, parallel-group study of the efficacy and safety of travoprost 0.004% compared with latanoprost 0:005%/timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension.一项为期6周的双盲平行组研究，比较0.004%曲伏前列素与0.005%拉坦前列素/0.5%噻吗洛尔治疗原发性开角型青光眼或高眼压症患者的疗效和安全性。
Clin Ther. 2006 Mar;28(3):332-9. doi: 10.1016/j.clinthera.2006.03.001.
3
The influence of diclofenac ophthalmic solution on the intraocular pressure-lowering effect of topical 0.5% timolol and 0.005% latanoprost in primary open-angle glaucoma patients.双氯芬酸眼药水对原发性开角型青光眼患者局部使用0.5%噻吗洛尔和0.005%拉坦前列素降眼压效果的影响。
Exp Eye Res. 2005 Nov;81(5):610-5. doi: 10.1016/j.exer.2005.03.020. Epub 2005 Jun 8.
4
Effect of non-steroidal anti-inflammatory ophthalmic solution on intraocular pressure reduction by latanoprost.非甾体抗炎眼药水对拉坦前列素降低眼压作用的影响。
Br J Ophthalmol. 2003 Mar;87(3):297-301. doi: 10.1136/bjo.87.3.297.
5
A 6-week, multicenter, randomized, double-masked, parallel-group study comparing travoprost 0.004% to latanoprost 0.005% followed by 6-week, open-label treatment with travoprost 0.004%.一项为期6周的多中心随机双盲平行组研究，比较0.004%曲伏前列素与0.005%拉坦前列素，随后进行为期6周的0.004%曲伏前列素开放标签治疗。
Clin Ther. 2007 Sep;29(9):1915-23. doi: 10.1016/j.clinthera.2007.09.006.
6
Effectiveness and safety of dorzolamide-timolol alone or combined with latanoprost in open-angle glaucoma or ocular hypertension.多佐胺-噻吗洛尔单独使用或与拉坦前列素联合使用治疗开角型青光眼或高眼压症的有效性和安全性。
Ann Pharmacother. 2008 Apr;42(4):498-504. doi: 10.1345/aph.1K565. Epub 2008 Mar 25.
7
Circadian intraocular pressure control with dorzolamide versus timolol maleate add-on treatments in primary open-angle glaucoma patients using latanoprost.在使用拉坦前列素的原发性开角型青光眼患者中，用多佐胺与马来酸噻吗洛尔附加治疗进行昼夜眼压控制的比较
Ophthalmic Res. 2007;39(1):24-31. doi: 10.1159/000097903. Epub 2006 Dec 11.
8
Topical and oral ketorolac administration increases the intraocular pressure-lowering effect of latanoprost.局部和口服酮咯酸给药可增强拉坦前列素的降眼压作用。
Curr Eye Res. 2008 May;33(5):477-82. doi: 10.1080/02713680802100845.
9
Nimesulide oral administration increases the intraocular pressure-lowering effect of latanoprost in patients with primary open-angle glaucoma.口服尼美舒利可增强拉坦前列素对原发性开角型青光眼患者的降眼压效果。
Am J Ophthalmol. 2006 Feb;141(2):379-81. doi: 10.1016/j.ajo.2004.11.062.
10
Circadian IOP-lowering efficacy of travoprost 0.004% ophthalmic solution compared to latanoprost 0.005%.0.004%曲伏前列素滴眼液与0.005%拉坦前列素相比的昼夜眼压降低疗效。
Curr Med Res Opin. 2006 Sep;22(9):1689-97. doi: 10.1185/030079906X120959.

引用本文的文献

1
Lipidomic Analysis Reveals Drug-Induced Lipoxins in Glaucoma Treatment.脂质组学分析揭示青光眼治疗中药物诱导的脂氧素
bioRxiv. 2025 Jan 27:2025.01.24.634771. doi: 10.1101/2025.01.24.634771.
2
The Roles Played by FP/EP3 Receptors During Pressure-lowering in Mouse Eyes Mediated by a Dual FP/EP3 Receptor Agonist.双重 FP/EP3 受体激动剂介导降压过程中 FP/EP3 受体在小鼠眼中的作用。
Invest Ophthalmol Vis Sci. 2022 Feb 1;63(2):24. doi: 10.1167/iovs.63.2.24.
3
Efficacy and safety of sodium bromfenac eye drops in the treatment of postoperative inflammation in cataract surgery: A protocol for systematic review and meta-analysis.溴芬酸钠滴眼液治疗白内障手术后炎症的疗效与安全性：系统评价与Meta分析方案
Medicine (Baltimore). 2020 Dec 4;99(49):e23131. doi: 10.1097/MD.0000000000023131.
4
The influence of topical non-steroidal anti-inflammatory drugs on the intraocular pressure lowering effect of topical prostaglandin analogues-A systemic review and meta-analysis.局部非甾体抗炎药对局部前列腺素类似物降低眼压效果的影响：系统评价和荟萃分析。
PLoS One. 2020 Sep 14;15(9):e0239233. doi: 10.1371/journal.pone.0239233. eCollection 2020.
5
Effect of a Topical Combination of Latanoprost and Pranoprofen on Intraocular Pressure and the Ocular Surface in Open-Angle Glaucoma Patients.拉坦前列素与普拉洛芬局部联合用药对开角型青光眼患者眼压及眼表的影响
J Ophthalmol. 2018 Dec 13;2018:7474086. doi: 10.1155/2018/7474086. eCollection 2018.
6
Contribution of prostanoid FP receptor and prostaglandins in transient inflammatory ocular hypertension.前列腺素 FP 受体和前列腺素在短暂性炎症性眼高压中的作用。
Sci Rep. 2018 Jul 23;8(1):11098. doi: 10.1038/s41598-018-29273-1.
7
Endogenous Bioactive Lipids and the Regulation of Conventional Outflow Facility.内源性生物活性脂质与传统房水引流通道的调节
Expert Rev Ophthalmol. 2008;3(4):457-470. doi: 10.1586/17469899.3.4.457.

本文引用的文献

1
Ocular hypotensive effects of cholinergic and adrenergic drugs may be influenced by prostaglandins E2 in the human and rabbit eye.胆碱能和肾上腺素能药物的降眼压作用可能会受到人眼和兔眼中前列腺素E2的影响。
Eur J Ophthalmol. 2003 Jan-Feb;13(1):18-23. doi: 10.1177/112067210301300103.
2
Effect of non-steroidal anti-inflammatory ophthalmic solution on intraocular pressure reduction by latanoprost.非甾体抗炎眼药水对拉坦前列素降低眼压作用的影响。
Br J Ophthalmol. 2003 Mar;87(3):297-301. doi: 10.1136/bjo.87.3.297.
3
Comparison between isopropyl unoprostone and latanoprost by prostaglandin E(2)induction, affinity to prostaglandin transporter, and intraocular metabolism.通过前列腺素E(2)诱导、对前列腺素转运体的亲和力及眼内代谢对异丙前列素和拉坦前列素进行比较。
Exp Eye Res. 2002 Jan;74(1):41-9. doi: 10.1006/exer.2001.1104.
4
Latanoprost and brimonidine: therapeutic and physiologic assessment before and after oral nonsteroidal anti-inflammatory therapy.拉坦前列素和溴莫尼定：口服非甾体抗炎治疗前后的治疗及生理评估
Am J Ophthalmol. 2002 Jan;133(1):11-8. doi: 10.1016/s0002-9394(01)01286-7.
5
Arachidonic acid release and prostaglandin E2 synthesis as irritant index of surfactants in 3T6 fibroblast cultures.花生四烯酸释放和前列腺素E2合成作为3T6成纤维细胞培养中表面活性剂刺激指数的研究
Toxicology. 2000 Mar 7;143(3):275-82. doi: 10.1016/s0300-483x(99)00175-4.
6
Effect of latanoprost or 8-iso prostaglandin E2 alone and in combination on intraocular pressure in glaucomatous monkey eyes.拉坦前列素或8-异前列腺素E2单独及联合应用对青光眼猴眼眼压的影响。
Arch Ophthalmol. 2000 Jan;118(1):74-7. doi: 10.1001/archopht.118.1.74.
7
Prostaglandins increase matrix metalloproteinase release from human ciliary smooth muscle cells.
Invest Ophthalmol Vis Sci. 1997 Dec;38(13):2772-80.
8
Prostaglandins alter extracellular matrix adjacent to human ciliary muscle cells in vitro.前列腺素在体外可改变人睫状肌细胞附近的细胞外基质。
Invest Ophthalmol Vis Sci. 1997 Oct;38(11):2214-23.
9
Clinical dose-regimen studies with latanoprost, a new ocular hypotensive PGF2 alpha analogue.新型降眼压前列腺素F2α类似物拉坦前列素的临床剂量方案研究。
Surv Ophthalmol. 1997 Feb;41 Suppl 2:S77-81. doi: 10.1016/s0039-6257(97)80011-2.
10
Prostaglandin action on ciliary smooth muscle extracellular matrix metabolism: implications for uveoscleral outflow.前列腺素对睫状肌细胞外基质代谢的作用：对葡萄膜巩膜外流的影响。
Surv Ophthalmol. 1997 Feb;41 Suppl 2:S53-9. doi: 10.1016/s0039-6257(97)80008-2.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验